The study identifies both lysosomal dysfunction and cholesterol metabolism disruption as consequences of ApoE4 in tauopathy, but whether these are independent effects or causally linked processes remains unclear. Resolving this could inform therapeutic targeting strategies. Gap type: unexplained_observation Source paper: Amelioration of Tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist. (2024, Neuron, PMID:37995685)
Landscape Summary: What is the relationship between lysosomal dysfunction and cholesterol metabolism perturbations in ApoE4-mediated tauopathy? is a 0.75 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
What is the relationship between lysosomal dysfunction and cholesterol metabolism perturbations in ApoE4-mediated tauopathy? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: